Abstract:Type 1 diabetes (T1D) results from immune-mediated destruction of pancreatic β-cells. Senescence and activation of a senescence-associated secretory phenotype (SASP) in β-cells may contribute to T1D pathogenesis; however, the mechanisms responsible for this phenotype are not well understood. We hypothesized that loss of endoplasmic reticulum (ER) Ca2+ induces mitochondrial dysfunction and drives the development of β-cell senescence during T1D. To test this hypothesis, we generated sarco/ER Ca2+-ATPase 2 (SERCA2) haploinsufficient mice on the NOD background (NOD-S2+/-). NOD-S2+/- mice displayed accelerated T1D onset compared to NOD-WT mice (14 wks vs 18 wks; p≤ 0.0001 female and 21 wks vs 24.5 wks male; p<0.05). As expected, basal ER Ca2+ levels were reduced in NOD-S2+/- islets, but basal mitochondrial Ca2+ levels were elevated compared to NOD-WT islets. Basal cytoplasmic Ca2+ levels remained unchanged. Single cell RNA sequencing showed an increase in immune cell markers in the NOD-S2+/- islets at 6 wks of age, with signatures of ER stress and mitochondrial dysfunction at both 6 and 10 wks of age. Islets from prediabetic female NOD-S2+/- mice showed decreased glucose-stimulated O2 consumption, reduced ATP production, and decreased mitochondrial membrane potential. Additionally, protein expression of ATP synthase and Complex III was decreased in female NOD-S2+/- islets, but mitochondrial content was unchanged. There was an increased expression of multiple markers of senescence and SASP in NOD-S2+/- islets between 6 and 12 wks of age compared to NOD-WT islets. Lastly, in vivo allosteric activation of SERCA decreased insulitis and delayed diabetes onset in WT NOD mice. Our results show that SERCA2 deficiency leads to mitochondrial dysfunction, β-cell senescence, and accelerated T1D development. In future studies, we will test whether senolytic agents can delay diabetes onset and rescue mitochondrial health in models of T1D and SERCA2 deficiency. Disclosure S. A. Weaver: Employee; Eli Lilly and Company. R. N. Bone: None. D. J. Acri: None. J. Kim: None. T. Kono: None. R. Dahl: None. D. L. Eizirik: None. F. Syed: None. C. Evans-molina: Advisory Panel; Provention Bio, Inc., DiogenX, Avotres Inc., Neurodon, MaiCell Therapeutics, Other Relationship; Isla Technology, Bristol-Myers Squibb Company, Nimbus Therapeutics, Research Support; Lilly, Astellas Pharma Inc. Funding National Institute of Diabetes and Digestive and Kidney Diseases (F31DK134168, R01DK093954, R01DK127308, R01DK127236, UC4DK104166, U01DK127786); U.S. Department of Veterans Affairs (I01BX001733, 2I01BX001733-05); JDRF (3-PDF-2017-385-A-N, 3-IND-2022-1235-I-X); National Center for Advancing Translational Sciences (UL1TR002529)

2142-P: Toll-Like Receptors 2 and 4 Act As Brakes to Regulate Adaptive SS-Cell Mass Expansion in Diet-Induced Obesity

Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab′)2 Antibody Treatment through Secreting Transforming Growth Factor-β

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

175-OR: the Mitochondrial Life Cycle Determines SS-Cell Maturity Through Activation of the Integrated Stress Response

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

203-OR: VGLL4 and MENIN Function As TEAD1 Corepressors to Block Pancreatic SS-Cell Proliferation

Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2

Reg2 Expression Is Required for Pancreatic Islet Compensation in Response to Aging and High-Fat Diet–Induced Obesity

Reversibility Ofβ-Cell-specific Transcript Factors Expression by Long-Term Caloric Restriction in Db/db Mouse

High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass

115-LB: Liver-Derived FGF21 Mediates the Promoting Effect of Glucagon Receptor Antagonism on Beta-Cell Regeneration in Type 2 Diabetic Mice

LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK

375-OR: Epigenetic Control of Beta-Cell Stress Response and Senescence

Synergistic Effect Of Erad And Autophagy In Preventing Proinsulin A Regation And Promoting Beta-Cell Survival

Abrogation of Toll-Like Receptor 4 Mitigates Obesity-Induced Oxidative Stress, Proinflammation, and Insulin Resistance Through Metabolic Reprogramming of Mitochondria in Adipose Tissue

296-LB: Loss of SERCA2 Induces Mitochondrial Dysfunction, Increases ß-Cell Senescence, and Accelerates Type 1 Diabetes Development

DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus

Insulin-Dependent Regulation of mTORC2-Akt-FoxO Suppresses TLR4 Signaling in Human Leukocytes: Relevance to Type 2 Diabetes

287-OR: Traf6 Directs a Noncanonical Role for Innate Immune Signaling in Pancreatic ß-Cells